These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35641601)

  • 21. Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data.
    Cho MC; Yoo S; Park J; Cho SY; Son H; Oh SJ; Paick JS
    BJU Int; 2019 May; 123(5A):E34-E42. PubMed ID: 30582661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
    Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Woo HH; Bolton DM; Laborde E; Jack G; Chin PT; Rashid P; Thavaseelan J; McVary KT
    J Sex Med; 2012 Feb; 9(2):568-75. PubMed ID: 22172161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
    Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective multi-center study elucidating patient experience after prostatic urethral lift.
    Shore N; Freedman S; Gange S; Moseley W; Heron S; Tutrone R; Brown T; Barkin J
    Can J Urol; 2014 Feb; 21(1):7094-101. PubMed ID: 24529008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine.
    Luo F; Sun HH; Su YH; Zhang ZH; Wang YS; Zhao Z; Li J
    Lasers Med Sci; 2017 May; 32(4):895-901. PubMed ID: 28293871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift.
    McVary KT; Gange SN; Shore ND; Bolton DM; Cowan BE; Brown BT; Te AE; Chin PT; Rukstalis DB; Roehrborn CG;
    J Sex Med; 2014 Jan; 11(1):279-87. PubMed ID: 24119101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population.
    Wang MQ; Guo LP; Zhang GD; Yuan K; Li K; Duan F; Yan JY; Wang Y; Kang HY; Wang ZJ
    BMC Urol; 2015 Apr; 15():33. PubMed ID: 25887036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients.
    Desai MM; Singh A; Abhishek S; Laddha A; Pandya H; Ashrafi AN; Ganpule AP; Roehrborn CG; Thomas AJ; Desai M; Sabnis RB
    BJU Int; 2018 Jun; 121(6):945-951. PubMed ID: 29319914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective α1 -blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms.
    Lee YC; Juan YS; Liu CC; Bao BY; Wang CJ; Wu WJ; Huang CN; Huang SP
    BJU Int; 2016 Aug; 118(2):313-9. PubMed ID: 26940040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
    Rukstalis D; Rashid P; Bogache WK; Tutrone RF; Barkin J; Chin PT; Woo HH; Cantwell AL; Cowan BE; Bolton DM
    BJU Int; 2016 Oct; 118 Suppl 3():14-22. PubMed ID: 27684483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results.
    Li Q; Duan F; Wang MQ; Zhang GD; Yuan K
    Chin Med J (Engl); 2015 Aug; 128(15):2072-7. PubMed ID: 26228221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower urinary tract symptoms in patients with advanced prostate cancer: What are the outcomes of androgen deprivation therapy?
    Akpayak IC; Shuaibu SI; Ofoha CG; Dakum NK; Ramyil VM; Onowa VE; Agbo CA; Nabasu LE; Galam ZZ
    Niger Postgrad Med J; 2020; 27(1):49-53. PubMed ID: 32003362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
    Roehrborn CG; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Herron S; Rashid P; Rukstalis DB
    Can J Urol; 2017 Jun; 24(3):8802-8813. PubMed ID: 28646935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia.
    Somwaru AS; Metting S; Flisnik LM; Nellamattathil MG; Sharma A; Katabathina VS
    BMC Urol; 2020 Oct; 20(1):153. PubMed ID: 33032577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined prostatic urethral lift and remodeling of the prostate and bladder neck: a modified transurethral approach in the treatment of symptomatic lower urinary tract obstruction.
    Schoenthaler M; Sievert KD; Schoeb DS; Miernik A; Kunit T; Hein S; Herrmann TRW; Wilhelm K
    World J Urol; 2018 Jul; 36(7):1111-1116. PubMed ID: 29450732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men.
    Lu Y; Fan S; Song Y; Liu K; Zhou K; Kang J; Wang S; Yang Y; Liu X
    World J Urol; 2021 Jul; 39(7):2645-2653. PubMed ID: 33141318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study.
    Baboudjian M; Fourmarier M; Gondran-Tellier B; Pradere B; Userovici M; Alegorides C; Barry Delongchamps N
    Int Urol Nephrol; 2021 Sep; 53(9):1757-1763. PubMed ID: 34052957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.